POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY

Detalles Bibliográficos
Autores principales: AHMAD, S., Bhasin, N., Sinha, S., Sayed, S.A., Bansode, J., Swami, R., Mehta, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049664/
http://dx.doi.org/10.1016/j.ekir.2021.03.494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049664/
http://dx.doi.org/10.1016/j.ekir.2021.03.494

Ejemplares similares